World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 25 March 2013
Main ID:  NCT00492817
Date of registration: 26/06/2007
Primary sponsor: M.D. Anderson Cancer Center
Public title: Evaluation of Single Session Stereotactic Body Radiotherapy
Scientific title: Phase I/II Evaluation of Single Session Stereotactic Body Radiotherapy for Spinal or Paraspinal Metastases
Date of first enrolment: October 2005
Target sample size: 60
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT00492817
Study type:  Interventional
Study design:  Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Paul Brown, MD
Address: 
Telephone:
Email:
Affiliation:  M.D. Anderson Cancer Center
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Radiographically documented spine or paraspinal metastasis demonstrated on spine MRI
within 4 weeks of registration

2. Maximum of 2 metastatic sites in the spine to be irradiated in single session

3. Informed consent for irradiation of spinal or para-spinal tumor (s)

4. Diagnosis of cancer including but not limited to lung (non-small cell and small
cell), breast, prostate, renal cell, melanoma, gastrointestinal, and germ cell
tumors, unknown primary tumors

5. Karnofsky performance status of at least 40 (ie not requiring active hospitalization)

Exclusion Criteria:

1. Worsening neurological status due to radiographic evidence of spinal cord compression
requiring immediate surgical decompression or emergent conventional external
radiation therapy.

2. Delay in initiation of radiation treatment would be potentially detrimental to
neurological outcome

3. Prior irradiation to current site of interest in the spine

4. Spinal metastasis in the cervical spine are not eligible for treatment

5. Unstable spine requiring surgical stabilization.

6. Sites outside the spine (eg. lung, liver) are not eligible for treatment

7. Patients currently receiving, or who have received chemotherapy within 30 days are
not eligible

8. Inability to tolerate lying flat on treatment couch for greater than 30 minutes.

9. Patient with multiple myeloma

10. Patients unable to undergo MRI of the spine

11. Patients with pacemakers



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Spinal Neoplasms
Intervention(s)
Procedure: Stereotactic Body Radiotherapy
Primary Outcome(s)
Safety and effectiveness of stereotactic body radiotherapy to the spine using computerized tomography (CT)-on-Rails in the treatment of metastatic spine tumors. [Time Frame: 5 Years]
Secondary Outcome(s)
Secondary ID(s)
2005-0445
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history